IP Library Patent Application 18613381
Patent Application Utility Small
App. No. 18/613,381 · Confirmation No. 7145

USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS

Non Final Action Mailed View Publication ↗
⬇ PDF
Code Description Pages PDF
2026-06-03 CTNF Non-Final Rejection 7 View
2026-06-03 SRFW Search information including classification, databases and other search related notes 1 View
2026-06-03 1449 List of References cited by applicant and considered by examiner 5 View
2026-06-03 BIB Bibliographic Data Sheet 1 View
2026-06-03 SRNT Examiner's search strategy and results 7 View
2024-07-15 NTC.PUB Notice of Publication 1 View
2024-05-22 N417 Electronic Filing System Acknowledgment Receipt 2 View
2024-05-22 IDS Information Disclosure Statement (IDS) Form (SB08) 5 View
2024-05-22 TRAN.LET Transmittal Letter 1 View
2024-04-28 M327 Miscellaneous Communication to Applicant - No Action Count 1 View
2024-04-28 M327 Miscellaneous Communication to Applicant - No Action Count 1 View
2024-04-02 APP.FILE.REC Filing Receipt 4 View
2024-04-02 WFEE Fee Worksheet (SB06) 1 View
2024-04-02 WELCOME.LET Welcome Letter from USPTO Director and Deputy Director 1 View
2024-03-22 SPEC Specification View
2024-03-22 SPEC Specification 25 View
2024-03-22 CLM Claims 1 View
2024-03-22 ABST Abstract 1 View
2024-03-22 N417.PYMT Electronic Fee Payment 2 View
2024-03-22 PA.. Power of Attorney 3 View
2024-03-22 ADS Application Data Sheet 9 View
2024-03-22 OATH Oath or Declaration filed 2 View
2024-03-22 N417 Electronic Filing System Acknowledgment Receipt 3 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
18/613,381
Filed
2024-03-22
Pub. No.
US20240226125A1
Art Unit
1699